$26.380
-0.327 (-1.24%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de VKTX por análisis de gráficos similares
Alphio's VKTX stock price prediction model matches the current Viking Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $26.65 (+1.04%). The 1-week path is $26.13 (-0.94%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Viking Therapeutics Inc?
Viking Therapeutics Inc (VKTX) is currently trading at $25.17, which is significantly below the analyst price targets of $85 and $120 from Truist and Oppenheimer, respectively. However, the stock has shown a 28.94% year-to-date decline, and the RSI is at a low 30.3, indicating oversold conditions. The company is facing substantial net losses, projected to reach -$158 million in Q1 2026, which raises concerns about its financial stability. The upcoming Phase 3 trials for VK2735 could be a potential catalyst for recovery, but the risks associated with competition and ongoing losses suggest a cautious approach. Given these factors, it may be prudent to hold VKTX for now and reassess after the trial results.
VKTX cerró en $26.38 el Wednesday, tras bajar -1.24%
Viking Therapeutics Inc (VKTX) last closed at $26.38, losing -1.24%. These facts feed the 1-day and 1-week VKTX price prediction above.
Consenso de analistas
Viking Therapeutics Inc (VKTX): 3 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Viking Therapeutics Inc (VKTX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de VKTX, ordenadas por similitud.
Análisis de estacionalidad de VKTX
Historically the probability of a positive October return for VKTX is 37.70%. July offers the highest probability of a positive month at 56.06%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de VKTX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $34.27 | $38.65 | $45.92 | +46.52% |
| Nov 2026 | $28.76 | $35.24 | $38.15 | +33.59% |
| Dec 2026 | $28.47 | $28.57 | $29.25 | +8.30% |
En 2026, se proyecta que Viking Therapeutics Inc (VKTX) oscile entre $28.47 y $45.92.
Previsión mensual de Viking Therapeutics Inc para 2026
En Oct de 2026, se proyecta que Viking Therapeutics Inc promedie $38.65, con un mínimo de $34.27 y un máximo de $45.92.
En Nov de 2026, se proyecta que Viking Therapeutics Inc promedie $35.24, con un mínimo de $28.76 y un máximo de $38.15.
En Dec de 2026, se proyecta que Viking Therapeutics Inc promedie $28.57, con un mínimo de $28.47 y un máximo de $29.25.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.